BIPROGY, JP3754200008

BIPROGY tests USDC payments: what it means for BIPROGY stock

Published on 10/20/2026 at 02:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
BIPROGY will test three USDC payment phases in real invoices with its U.S. unit. BIPROGY stock faces Q2 results on November 5, 2026.

Payment trial and results date

  • BIPROGY announced a three-phase USDC payment proof of concept on October 14, 2026.
  • First-quarter fiscal 2027 revenue fell 5.60 percent year over year to JPY 91.46 billion.
  • BIPROGY plans to announce second-quarter fiscal 2027 results on November 5, 2026.
BIPROGY, JP3754200008, Illustration mit AI erstellt.

BIPROGY announced a three-phase proof of concept for USDC cross-border payments on October 14, 2026, targeting actual invoices and payments to BIPROGY USA. The project gives BIPROGY stock a concrete technology and execution test before the group's second-quarter fiscal 2027 results, according to Kyodo News PR Wire.

Three phases define the trial

The first phase covers USDC transfers from BIPROGY's account or wallet to the wallet of its U.S. subsidiary. Later phases examine period-end token holdings and possible transfers outside the group, while also testing treasury management, accounting, supporting records and compliance procedures.

The plan matters because it links the stablecoin initiative to operating workflows rather than a simulated transaction. BIPROGY said it will assess payment instructions, transfer records, receipt confirmation and the differences from existing bank remittances.

Chronology adds an execution test

On September 7, 2026, BIPROGY began a strategic partnership with Serverworks and G-gen for cloud and generative artificial intelligence services. On October 7, 2026, first-quarter fiscal 2027 revenue fell 5.60 percent from the prior-year quarter to JPY 91.46 billion, while operating profit declined 20.40 percent to JPY 6.82 billion, according to IT Boltwise. On October 14, 2026, the company announced the USDC trial with three planned phases, as Kyodo News PR Wire reported.

What does the trial mean for growth?

The immediate financial counterweight is the first-quarter earnings decline: profit attributable to owners fell 23.10 percent year over year to JPY 4.48 billion. BIPROGY's fiscal 2027 plan calls for JPY 470.00 billion in revenue and JPY 48.40 billion in operating profit, representing increases of 8.40 percent and 13.60 percent from fiscal 2026.

That comparison places the payment project in a demanding setting. The stablecoin work can broaden BIPROGY's financial-services offering, but the next report must show whether the planned second-half acceleration is reaching revenue and operating profit.

Next reporting date matters

BIPROGY's investor-relations calendar schedules the second-quarter fiscal 2027 earnings announcement for November 5, 2026, while the first-quarter announcement was held on August 5, 2026, according to BIPROGY. The date is the next clear checkpoint for the cloud, artificial intelligence and financial-services strategy.

Market context stays valuation-focused

BIPROGY's market capitalization stood at JPY 489.0 billion in the October 2026 valuation data, and its price-to-earnings ratio was 16.40 times. The same analysis listed nine analysts and an average 12-month target of JPY 5,355.56, with a current share price of JPY 5,054.00, according to Simply Wall St. The figures frame the stock around execution: investors have a measurable growth plan, but the first-quarter comparison shows that delivery has yet to be even across the year.

Stock and company facts

BIPROGY at a glance

  • Company: BIPROGY Inc.
  • ISIN: JP3754200008
  • Ticker: 8056
  • Primary exchange: TSE
  • Market capitalization: JPY 489.0 billion (October 2026)
  • 52-week range: JPY 4,036.00-6,273.00 (October 7, 2026)
  • Sector / Industry: Technology / Information Technology Services
  • Next earnings date: November 5, 2026

Market context: Market report Nikkei 225.

More news and analyses on BIPROGY stock

Disclaimer...
en | JP3754200008 | BIPROGY | boerse | 70367852 | bgmi